Abbott StarClose Opens Vascular Closure Options; U.S. Launch Set For 2005
Abbott believes its StarClose vascular closure device will represent a competitive alternative to St. Jude's market leading AngioSeal upon U.S. approval in 2005
Abbott believes its StarClose vascular closure device will represent a competitive alternative to St. Jude's market leading AngioSeal upon U.S. approval in 2005